AUD 0.02
(0.0%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | -815.99 Thousand | -2.97 Million | -1.89 Million | -1.46 Million | -3.13 Million | -2.64 Million |
Net Income | -931.61 Thousand | -3.24 Million | -2.36 Million | -1.98 Million | -1.87 Million | -3.24 Million |
Depreciation & Amortization | 19 Thousand | 17.13 Thousand | 3115.04 | 26.87 Thousand | 79.7 Thousand | 819.03 |
Deferred income taxes | - | - | - | - | - | 151.69 Thousand |
Stock-based compensation | 27.87 Thousand | 230.69 Thousand | 386.66 Thousand | 492.14 Thousand | 18.66 Thousand | - |
Change in working capital | -57.21 Thousand | 43.39 Thousand | 100.87 Thousand | -8858.57 | -1.36 Million | -469.8 Thousand |
Other non-cash items | 125.95 Thousand | 213.93 Thousand | 368.12 Thousand | 495.27 Thousand | 22.38 Thousand | 600.85 Thousand |
Investing Cash Flow | -1521.00 | -11.99 Thousand | -2775.82 | -32.11 Thousand | -7861.30 | -37.36 Thousand |
Investments in PPE | -1521.00 | -11.99 Thousand | -2775.82 | - | -7861.30 | -2086.00 |
Acquisitions | - | - | - | - | - | -49.32 Thousand |
Investment purchases | - | - | - | - | - | -35.27 Thousand |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | - | - | - | 49.32 Thousand |
Financing Cash Flow | 479.73 Thousand | 470.7 Thousand | 2.53 Million | 3.12 Million | 3.29 Million | 1.65 Million |
Debt repayment | -57.62 Thousand | -492.82 Thousand | - | -23.08 Thousand | -307.12 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | -3548.00 | -870.00 | -145.46 Thousand | -188.59 Thousand | -97.94 Thousand | -87.82 Thousand |
Common Stock Issuance | 551.99 Thousand | -1293.40 | 2.53 Million | 3.14 Million | 3.06 Million | 1.74 Million |
Other Financing Activities | -11.07 Thousand | 971.64 Thousand | 145.46 Thousand | 165.39 Thousand | 705.32 Thousand | - |
Accounts receivables | -57.21 Thousand | -14.51 Thousand | -1734.72 | 18 Thousand | 52.14 Thousand | -469.8 Thousand |
Accounts payables | 6494.86 | 78.74 Thousand | 102.61 Thousand | -26.86 Thousand | -1.56 Million | 495.7 Thousand |
Inventory | - | -1.00 | - | - | 1.00 | -510.59 Thousand |
Other working capital | - | -20.83 Thousand | -0.28 | -0.57 | 151.48 Thousand | 14.89 Thousand |
Cash at beginning of period | 135.46 Thousand | 2.56 Million | 1.83 Million | 224.53 Thousand | 70.93 Thousand | 323.33 Thousand |
Cash at end of period | 26.71 Thousand | 203.5 Thousand | 2.56 Million | 1.83 Million | 224.53 Thousand | 27.34 Thousand |
Capital Expenditure | -1521.00 | -11.99 Thousand | -2775.82 | - | -7861.30 | -2086.00 |
Effect of forex changes on cash | -105.00 | 63.58 Thousand | -77.16 Thousand | -8846.00 | 5616.00 | -39.18 Thousand |
Net cash flow / Change in cash | -108.74 Thousand | -2.35 Million | 727.27 Thousand | 1.6 Million | 153.59 Thousand | -295.98 Thousand |
Free Cash Flow | -817.51 Thousand | -2.98 Million | -1.89 Million | -1.46 Million | -3.14 Million | -2.64 Million |
Breakdown | 2024 FY | 2024 Q4 | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | -951.6 Thousand | -322.8 Thousand | -630.08 Thousand | -1.45 Million | -3.24 Million | -1.75 Million |
Depreciation & Amortization | 1787.00 | - | 24.17 Thousand | 16.25 Thousand | 17.13 Thousand | 800.55 |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | 68.95 Thousand | 230.69 Thousand | 158.23 Thousand |
Change in working capital | - | - | - | -35.7 Thousand | 43.39 Thousand | - |
Other non-cash items | 57.81 Thousand | 26.78 Thousand | 58.61 Thousand | 196.19 Thousand | 213.93 Thousand | -52.25 Thousand |
Investing Cash Flow | -2321.12 | -2311.02 | - | -11.94 Thousand | -11.99 Thousand | - |
Investments in PPE | -2321.12 | 291.11 Thousand | - | -11.94 Thousand | -11.99 Thousand | - |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | -2311.02 | - | - | - | - |
Financing Cash Flow | 732.1 Thousand | 188.36 Thousand | 540.55 Thousand | 468.67 Thousand | 470.7 Thousand | - |
Debt repayment | -87.94 Thousand | -87.56 Thousand | -283.04 Thousand | -490.7 Thousand | -492.82 Thousand | - |
Dividends payments | - | - | - | - | - | - |
Common Stock Repurchased | - | - | - | - | -870.00 | - |
Common Stock Issuance | 836.95 Thousand | -7256.67 | 840.56 Thousand | -1287.83 | -1293.40 | - |
Other Financing Activities | - | 199.65 | 533.71 Thousand | 475.37 Thousand | 971.64 Thousand | - |
Accounts receivables | - | - | - | -14.66 Thousand | -14.51 Thousand | - |
Accounts payables | - | - | - | - | 78.74 Thousand | - |
Inventory | - | - | - | - | -1.00 | - |
Other working capital | - | - | - | -21.03 Thousand | -20.83 Thousand | - |
Cash at beginning of period | 203.5 Thousand | 140.74 Thousand | 203.5 Thousand | 871.45 Thousand | 2.56 Million | 2.56 Million |
Cash at end of period | 40 Thousand | 40 Thousand | 140.58 Thousand | 203.5 Thousand | 203.5 Thousand | 868.08 Thousand |
Capital Expenditure | -2321.12 | 291.11 Thousand | - | -11.94 Thousand | -11.99 Thousand | - |
Effect of forex changes on cash | - | - | -5264.31 | 163.94 Thousand | 63.58 Thousand | -67 Thousand |
Net cash flow / Change in cash | -163.49 Thousand | -100.73 Thousand | -62.92 Thousand | -667.95 Thousand | -2.35 Million | -1.69 Million |
Free Cash Flow | -897.89 Thousand | -4907.00 | -595.64 Thousand | -1.29 Million | -2.98 Million | -1.65 Million |
BAIDFIN
COCKERILL
NXG
MEDS
SUDTIND-B
8244